Skipping Exon-v6 from CD44v6-Containing Isoforms Influences Chemotherapy Response and Self-Renewal Capacity of Gastric Cancer Cells.

Lobo, Silvana; Pereira, Carla; Oliveira, Carla; Almeida, Gabriela M

Lobo, Silvana; Pereira, Carla; Oliveira, Carla; Almeida, Gabriela M.

Afiliación

Lobo S; i3s-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.
Pereira C; IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.
Oliveira C; i3s-Instituto de Investigação e Inovação em Saúde, 4200-135 Porto, Portugal.
Almeida GM; IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.

Cancers (Basel) ; 12(9)2020 Aug 22.

Article en En | MEDLINE | ID: mdl-32842638

Palabras clave

CRISPR/Cas9; cell survival; chemoresistance; exon skipping; morpholinos; stomach neoplasms

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2020 Tipo del documento: Article País de afiliación: Portugal

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google